In the course of their mission-critical research, FDA scientists regularly gain new scientific insights and invent new technologies. products, or processes. FDA's Technology Transfer team helps move these technologies to the private sector under license agreements so that new products in areas like vaccines, food-pathogen detection systems, counterfeit drug detection, and manufacturing can be created and made available on the market. In the last few years alone, FDA researchers have produced and reported about 20 patentable inventions annually. And FDA holds over 600 invention properties of which about 15 percent are licensed for development.
Under the Federal Technology Transfer Act of 1986 FDA and each of our technical employees are responsible for developing opportunities to transfer technology. One technology transfer mechanism is the patenting and licensing of FDA inventions, which are owned by the Federal government. Patenting and licensing are used to help ensure that Federal technologies are fully developed and made available to the public.
In working to meet the missions of FDA product centers and offices, FDA scientists have discovered and developed a broad range of technologies. To view FDA technologies that are available for licensing visit the Available Technologies Search Tool at the Federal Laboratory Consortium website or the NIH Office of Technology Transfer website.
For more information please contact Alice Welch, Director of FDA’s Technology Transfer Program.